ZYUS

ZYUS Life Sciences is a Canadian-based life sciences company specializing in the global development and commercialization of cannabinoid-based pharmaceutical drug products and innovative exempt market therapeutics. The company focuses on advancing the science of well-being by elevating cannabinoid formulations as a standard of care and expanding the potential of protein-based formulations. ZYUS serves patients who seek alternative and effective treatments for pain and other conditions, operating primarily in the medical and pharmaceutical markets. The business model revolves around clinical research, intellectual property protection, and the production of high-quality, compliant cannabinoid products. Revenue is generated through the sale of these pharmaceutical products and therapeutics in the global medical market.

Keywords: cannabinoid therapeutics, pharmaceutical, clinical research, intellectual property, patient well-being, protein-based formulations, medical market, pain management, cGMP, EU GMP.